BNY Mellon Mid Cap Stock Inv
200 Park Avenue The Dreyfus Corporation New York NY 10166
Map
Phone: 800-645-6561
| Category: | Mid-Cap Growth | | Fund Family: | Mellon Funds | | Net Assets: | 20.19M | | Year-to-Date Return: | 24.90% | | Yield: | 0.34% | | Morningstar Rating: |  | | Fund Inception Date: | 11-Jul-01 |
|
Stephen A. Mozur
Lead Manager since
30-Dec-04 | | | Mozur is a vice president at The Glenmede Trust Company, his employer since February 1998. Prior to joining the firm, he was responsible for portfolio management and research at both Newbold's Asset Management and Pilgrim Baxter & Associates. Mozur is a Chartered Financial Analyst and a Certified Public Accountant. He is a member of Glenmede's Institutional Policy and Strategy Committee. |
| Min Initial Investment: | $10,000 | | Min Initial Investment, IRA: | $10,000 | | Min Initial Investment, AIP: | $10,000 | | Min Subsequent Investment: | $100 | | Min Subsequent Investment, IRA: | N/A | | Min Subsequent Investment, AIP: | $100 |
|
| |
| The investment seeks capital appreciation. The fund normally invests at least 80% of assets in stocks of mid-cap domestic companies. The fund may purchase securities of companies in initial public offerings or shortly thereafter. It invests in growth and value stocks, which are chosen through a disciplined investment process that combines computer modeling techniques, fundamental analysis and risk management. The funds investment process is designed to provide investors with investment exposure to sector weightings and risk characteristics generally similar to those of the S&P Midcap 400 index. |
| Last Dividend
(9-Dec-09):
| 0.04 | | Last Cap Gain
(27-Mar-09):
| 0.01 | | Annual Holdings Turnover
| 147.50% | | Average for Category:
| 132.16% |
|
| Expense | MIMSX | Category
Avg | | Total Expense Ratio: | %
| 1.46% | | Max 12b1 Fee: | %
| N/A | | Max Front End Sales Load: | %
| 5.39% | | Max Deferred Sales Load: | %
| 2.68% | | 3 Yr Expense Projection*: |
$ YFT_NOT_APPLICABLE_ABBREVIATION | $707 | | 5 Yr Expense Projection*: |
$ YFT_NOT_APPLICABLE_ABBREVIATION | $1,038 | | 10 Yr Expense Projection*: |
$ YFT_NOT_APPLICABLE_ABBREVIATION | $2,057 |
|
|
0.20% Nasdaq 
Profile
